Advanced search
1 file | 485.43 KB Add to list

Future Perspectives on the Relevance of Auditory Markers in Prodromal Parkinson's Disease

Evelien De Groote (UGent) , Kim De Keyser (UGent) , Patrick Santens (UGent) , Durk Talsma (UGent) , Annelies Bockstael (UGent) , Dick Botteldooren (UGent) and Miet De Letter (UGent)
Author
Organization
Abstract
Research on auditory processing in Parkinson's disease (PD) has recently made substantial progress. At present, evidence has been found for altered auditory processing in the clinical stage of PD. The auditory alterations in PD have been demonstrated with low-cost and non-invasive assessments that are already used in routine clinical practice. Since auditory alterations have been reported early in disease progression, it would be highly relevant to investigate whether auditory markers could be provided in the prodromal stage of PD. In addition, auditory alterations in early stage PD might be modulated by dopaminergic medication. Therefore, the aim of this review is (1) to summarize the literature on auditory processing in PD with a specific focus on the early disease stages, (2) to give future perspectives on which audiological and electrophysiological measurements could be useful in the prodromal stage of PD and (3) to assess the effect of dopaminergic medication on potential auditory markers in the prodromal stage of PD.
Keywords
EVENT-RELATED POTENTIALS, SPEECH-PERCEPTION DEFICITS, IMPAIRED NOVELTY, DETECTION, MISMATCH NEGATIVITY MMN, SELECTIVE-ATTENTION, STARTLE, RESPONSE, TEMPORAL DISCRIMINATION, DOPAMINERGIC MEDICATION, HEARING, IMPAIRMENT, NONMOTOR SYMPTOMS, Parkinson's disease, auditory processing, prodromal markers, audiometry, otoacoustic emissions, dichotic listening, auditory reflexes, auditory, evoked potentials

Downloads

  • 8672056.pdf
    • full text (Published version)
    • |
    • open access
    • |
    • PDF
    • |
    • 485.43 KB

Citation

Please use this url to cite or link to this publication:

MLA
De Groote, Evelien, et al. “Future Perspectives on the Relevance of Auditory Markers in Prodromal Parkinson’s Disease.” FRONTIERS IN NEUROLOGY, vol. 11, Frontiers Media Sa, 2020, doi:10.3389/fneur.2020.00689.
APA
De Groote, E., De Keyser, K., Santens, P., Talsma, D., Bockstael, A., Botteldooren, D., & De Letter, M. (2020). Future Perspectives on the Relevance of Auditory Markers in Prodromal Parkinson’s Disease. FRONTIERS IN NEUROLOGY, 11. https://doi.org/10.3389/fneur.2020.00689
Chicago author-date
De Groote, Evelien, Kim De Keyser, Patrick Santens, Durk Talsma, Annelies Bockstael, Dick Botteldooren, and Miet De Letter. 2020. “Future Perspectives on the Relevance of Auditory Markers in Prodromal Parkinson’s Disease.” FRONTIERS IN NEUROLOGY 11. https://doi.org/10.3389/fneur.2020.00689.
Chicago author-date (all authors)
De Groote, Evelien, Kim De Keyser, Patrick Santens, Durk Talsma, Annelies Bockstael, Dick Botteldooren, and Miet De Letter. 2020. “Future Perspectives on the Relevance of Auditory Markers in Prodromal Parkinson’s Disease.” FRONTIERS IN NEUROLOGY 11. doi:10.3389/fneur.2020.00689.
Vancouver
1.
De Groote E, De Keyser K, Santens P, Talsma D, Bockstael A, Botteldooren D, et al. Future Perspectives on the Relevance of Auditory Markers in Prodromal Parkinson’s Disease. FRONTIERS IN NEUROLOGY. 2020;11.
IEEE
[1]
E. De Groote et al., “Future Perspectives on the Relevance of Auditory Markers in Prodromal Parkinson’s Disease,” FRONTIERS IN NEUROLOGY, vol. 11, 2020.
@article{8673754,
  abstract     = {{Research on auditory processing in Parkinson's disease (PD) has recently made substantial progress. At present, evidence has been found for altered auditory processing in the clinical stage of PD. The auditory alterations in PD have been demonstrated with low-cost and non-invasive assessments that are already used in routine clinical practice. Since auditory alterations have been reported early in disease progression, it would be highly relevant to investigate whether auditory markers could be provided in the prodromal stage of PD. In addition, auditory alterations in early stage PD might be modulated by dopaminergic medication. Therefore, the aim of this review is (1) to summarize the literature on auditory processing in PD with a specific focus on the early disease stages, (2) to give future perspectives on which audiological and electrophysiological measurements could be useful in the prodromal stage of PD and (3) to assess the effect of dopaminergic medication on potential auditory markers in the prodromal stage of PD.}},
  articleno    = {{689}},
  author       = {{De Groote, Evelien and De Keyser, Kim and Santens, Patrick and Talsma, Durk and Bockstael, Annelies and Botteldooren, Dick and De Letter, Miet}},
  issn         = {{1664-2295}},
  journal      = {{FRONTIERS IN NEUROLOGY}},
  keywords     = {{EVENT-RELATED POTENTIALS,SPEECH-PERCEPTION DEFICITS,IMPAIRED NOVELTY,DETECTION,MISMATCH NEGATIVITY MMN,SELECTIVE-ATTENTION,STARTLE,RESPONSE,TEMPORAL DISCRIMINATION,DOPAMINERGIC MEDICATION,HEARING,IMPAIRMENT,NONMOTOR SYMPTOMS,Parkinson's disease,auditory processing,prodromal markers,audiometry,otoacoustic emissions,dichotic listening,auditory reflexes,auditory,evoked potentials}},
  language     = {{eng}},
  pages        = {{17}},
  publisher    = {{Frontiers Media Sa}},
  title        = {{Future Perspectives on the Relevance of Auditory Markers in Prodromal Parkinson's Disease}},
  url          = {{http://dx.doi.org/10.3389/fneur.2020.00689}},
  volume       = {{11}},
  year         = {{2020}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: